FDA Approves Boxed Warning for Essure
The new label for the permanent contraceptive device highlights possible adverse events such as perforation of the uterus or fallopian tubes. News Alerts …read more
Abortion by Mail Allows Better Access But Political Questions Remain
The experiment — involving 50 women in Hawaii, Oregon, New York and Washington — breaks ground by letting women get an abortion without visiting a clinic. Kaiser Health News …read more
FDA Clears New Drug for Pregnancy-Related Nausea/Vomiting
Bonjesta is a fixed-dose combination of doxylamine succinate and pyridoxine HCI for pregnancy-related nausea and vomiting in women in whom conservative management fails. FDA Approvals …read more
Stress urinary incontinence drug’s benefits do not outweigh harms
A new study indicates that the benefits of duloxetine, a drug used in Europe to treat stress incontinence in women, do not outweigh the harms. …read more